FALCON POINT CAPITAL, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 54 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
FALCON POINT CAPITAL, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2018$192,000
+22.3%
31,208
+112.5%
0.04%
+32.3%
Q2 2018$157,000
-40.8%
14,687
-40.6%
0.03%
-41.5%
Q1 2018$265,000
+54.1%
24,714
+0.4%
0.05%
+82.8%
Q4 2017$172,000
-45.4%
24,625
-44.3%
0.03%
-37.0%
Q3 2017$315,00044,2190.05%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2017
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders